---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-061639"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2025-07-07T23:59:59+00:00"
generated_at: "2026-05-18T09:20:51.979490+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics CFO resigns; appoints Jeffrey Ervin as part-time CFO effective July 1, 2025

## Summary
- CFO Alexander Epshinsky resigned June 30, 2025; not due to any disagreement with the company.
- Jeffrey S. Ervin appointed part-time CFO on July 1, 2025; annual base salary of $175,000.
- Ervin previously served as fractional co-CFO of DDC Enterprise (NYSE: DDC) and chairman/CEO of IMAC Holdings (Nasdaq: BACK).
- Ervin also serves as independent director of Cingulate, Inc. (Nasdaq: CING); holds MBA from Vanderbilt.
- Severance: 6 months' base salary if terminated after Change-of-Control, subject to signed release.

## SEC filing metadata
- accession: 0001213900-25-061639
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2025-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390025061639/0001213900-25-061639-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390025061639/ea0248238-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-061639
- JSON: https://secwatch.observer/filing/0001213900-25-061639.json
- Plain text: https://secwatch.observer/filing/0001213900-25-061639.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.